Dean C Singleton
6PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Aug 14, 2024
Megakaryocyte maturation involves activation of the adaptive unfolded protein response.Mifra Faiz, Maggie L Kalev-Zylinska, Caitlin Dunstan-Harrison
|Sep 01, 2022
In vitro breast cancer models for studying mechanisms of resistance to endocrine therapy.Gary J Cheng, Euphemia Y Leung, Dean C Singleton
|Nov 27, 2021
Bioreductive prodrug PR-104 improves the tumour distribution and titre of the nitroreductase-armed oncolytic adenovirus ONYX-411NTR leading to therapeutic benefit.Dean C Singleton, Alexandra M Mowday, Chris P Guise
|Jul 30, 2021
Therapeutic targeting of the hypoxic tumour microenvironment.Dean C Singleton, Andrew Macann, William R Wilson
|May 27, 2020
Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer.Dean C Singleton, Anne-Lise Dechaume, Pamela M Murray
|Jan 08, 2019
Hypoxia-Activated Prodrugs of PERK Inhibitors.Lydia P Liew, Dean C Singleton, Way W Wong
Pageof 1
Frequent Collaborators
2 joint publications
Gary J Cheng
2 joint publications
Michael P Hay
2 joint publications
William R Wilson
1 joint publications
Lydia P Liew
1 joint publications
Stephen M F Jamieson
1 joint publications
Andrew Macann
1 joint publications
Alexandra M Mowday
1 joint publications
Amir Ashoorzadeh
1 joint publications
Jeff B Smaill
1 joint publications
Adam V Patterson
